Many human cancers exhibit high GCSF and/or GCSFR expression, including colorectal, breast, lung, ovarian, and pancreatic (23–27), and GCSF has been associated with tumor progression and poor therapy responses (24, 45, 47–50). The gene discussed is CSF3; the disease is neoplasm.